SHL Telemedicine Ltd. Shareholder Meeting Approves Compensation Policy
Ticker: SHMLF · Form: 6-K · Filed: May 9, 2024 · CIK: 1166834
| Field | Detail |
|---|---|
| Company | Shl Telemedicine Ltd (SHMLF) |
| Form Type | 6-K |
| Filed Date | May 9, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: governance, compensation, shareholder-meeting
TL;DR
SHL Telemedicine shareholders approved the exec comp policy for 3 years.
AI Summary
On May 9, 2024, SHL Telemedicine Ltd. held a Special General Meeting of Shareholders where the Compensation Policy for Executive Officers and Directors was approved. This policy will be in effect for a period of three years from the meeting date.
Why It Matters
Shareholder approval of executive compensation policies is crucial for corporate governance and can impact executive retention and company performance.
Risk Assessment
Risk Level: low — This filing is a routine update on a shareholder-approved policy and does not indicate significant new risks.
Key Players & Entities
- SHL Telemedicine Ltd. (company) — Registrant
- May 9, 2024 (date) — Date of Meeting and Announcement
FAQ
What was the primary purpose of the Special General Meeting of Shareholders held on May 9, 2024?
The primary purpose was to approve the Company's Compensation Policy for Executive Officers and Directors.
What is the duration for which the approved Compensation Policy will be effective?
The Compensation Policy is approved for a period of three years from the date of the Meeting.
Who is the registrant filing this report?
The registrant is SHL Telemedicine Ltd.
What is the address of SHL Telemedicine Ltd.'s principal executive offices?
The address is 90 Yigal Alon Street, Tel Aviv 67891, Israel.
What type of report is SHL Telemedicine Ltd. filing?
SHL Telemedicine Ltd. is filing a Form 6-K, which is a Report of Foreign Private Issuer.
Filing Stats: 298 words · 1 min read · ~1 pages · Grade level 11.9 · Accepted 2024-05-09 16:05:23
Filing Documents
- zk2431421.htm (6-K) — 10KB
- exhibit_99-1.htm (EX-99.1) — 5KB
- image0.jpg (GRAPHIC) — 142KB
- image00002.jpg (GRAPHIC) — 6KB
- 0001178913-24-001671.txt ( ) — 221KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File Number: 001-41641 SHL TELEMEDICINE LTD. (Translation of registrant's name into English) 90 Yigal Alon Street Tel Aviv 67891, Israel (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F EXPLANATORY NOTE On May 9, 2024, SHL Telemedicine Ltd. (the "Company") announced that at the Special General Meeting of Shareholders of the Company held on May 9, 2024 (the "Meeting"), the sole proposal to approve the Company's Compensation Policy for Executive Officers and Directors (the "Compensation Policy") for a period of three years from the date of the Meeting was approved by the shareholders. A copy of the press release issued by the Company on May 9, 2024, and announcing the approval of the Compensation Policy is attached hereto as Exhibit 99.1 and is incorporated by reference herein. This Form 6-K is incorporated by reference into the Company's Registration Statement on Form S-8 filed with the Securities and Exchange Commission on June 9, 2023 (Registration No. 333-272546), and its Registration Statement on Form 20FR12B/A filed with the Securities and Exchange Commission on March 28, 2023 (File No. 001-41641). Exhibit Description 99.1 Press release, dated May 9, 2024, announcing the results of the Special General Meeting of Shareholders. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. SHL Telemedicine Ltd. By: /s/ Amir Hai Amir Hai Chief Financial Officer May 9, 2024